📰 Affinity Technologies News
Page 10 - Affinity Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Affinity Technologies. Real-time updates on events, politics, business and more.
September 6, 2022
/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today bioAffinity Technologies,...
September 1, 2022
/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bio-Affinity...
August 27, 2022
Six small deals priced this past week, though only three met the criteria for our 2022 IPO stats.
May 27, 2022
BioAffinity Technologies, Inc. (BIAF) plans to raise $10 million in an IPO on Tuesday, May 31st, IPO Scoop reports. The company will be issuing 1,500,000 shares at a price of $6.75 per share. WallachBeth Capital acted as the underwriter for the IPO. bioAffinity Technologies, Inc. provided the following description of their company for its IPO: […]
April 28, 2022
BioAffinity Technologies has filed to raise capital via a U.S. IPO. The firm is developing a lung cancer detection test. Read what to know about the IPO here.
February 4, 2021
Search jobs 04-Feb-2021 bioAffinity Technologies Executes Agreement with Fosun Long March to Evaluate CyPath® Lung for Commercialization in China China’s leading healthcare company to evaluate bioAffinity’s non-invasive, highly accurate test for early-stage lung cancer with aim to commercialize in world’s largest market SAN ANTONIO--(BUSINESS WIRE)--#TCPP--Shanghai Fosun Long March Medical Science Co., Ltd. (Fosun Long March) has executed a no...